Evidence map›Paper›PMID 36232738›Full record

ReviewInternational journal of molecular sciences2022

miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?

Léa Toury, Diane Frankel, Coraline Airault, Frédérique Magdinier, Patrice Roll, Elise Kaspi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Cellular senescence in skeletal disease: mechanisms and treatment.Cellular & molecular biology letters · 2023
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Léa TouryAix Marseille Univ, INSERM, MMG, 13005 Marseille, France.ORCID 0000-0003-2148-9768
Diane FrankelAix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, 13005 Marseille, France.ORCID 0000-0003-3321-6951
Coraline AiraultAix Marseille Univ, INSERM, MMG, 13005 Marseille, France.ORCID 0000-0001-6526-0135
Frédérique MagdinierAix Marseille Univ, INSERM, MMG, 13005 Marseille, France.ORCID 0000-0002-0159-9559
Patrice RollAix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, 13005 Marseille, France.ORCID 0000-0002-0045-5641
Elise KaspiAix Marseille Univ, APHM, INSERM, MMG, Hôpital la Timone, Service de Biologie Cellulaire, 13005 Marseille, France.ORCID 0000-0003-0458-5109
Inserm · FR

Funding

Association Française contre les Myopathies (AFM-Telethon) 23408
6 · The paper itself

Abstract

microRNAs (miRNAs) are small single strand non-coding RNAs and powerful gene expression regulators. They mainly bind to the 3'UTR sequence of targeted mRNA, leading to their degradation or translation inhibition.

Indexed as

MicroRNAsRNA, Long Noncoding3' Untranslated RegionsBiomarkersRNA, Messenger3' Untranslated RegionsBiomarkersMicroRNAsRNA, Long NoncodingRNA, Messengeraging-related diseasesmicroRNAmiR-140

Identifiers

PMID36232738
PMCPMC9570089
OpenAlexW4297477899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.